Current State of Diagnosis and Management of Critical Limb Ischemia

被引:0
作者
Dan Clair
Samir Shah
John Weber
机构
[1] Cleveland Clinic Lerner College of Medicine,Department of Vascular Surgery
来源
Current Cardiology Reports | 2012年 / 14卷
关键词
Critical limb ischemia; Tissue loss; CLI; Peripheral arterial disease; PAD; TASC; BASIL; Rest pain; Atherosclerosis; Claudication; Limb salvage; Gangrene; Amputation; Peripheral bypass; Aortoiliac disease; Infrainguinal disease; Endovascular;
D O I
暂无
中图分类号
学科分类号
摘要
Critical limb ischemia represents the most severe form of peripheral arterial disease and carries with it severe morbidity and mortality risks. Because of comorbidity risks, early diagnosis and aggressive medical management make up an important part of the treatment paradigm for these individuals. However, in addition to managing these comorbid conditions, the physician caring for these individuals must be able to provide revascularization options that will improve arterial flow to the threatened extremity and assure healing of complicated wounds. Both open surgical and endovascular therapies have proven beneficial in restoring flow to severely ischemic limbs in these patients. Additionally, combinations of the above therapeutic methods have offered more available options for these patients. This article reviews care of patients with critical limb ischemia with critical assessment of options for medical and revascularization options.
引用
收藏
页码:160 / 170
页数:10
相关论文
共 134 条
[1]  
Ostchega Y(2007)Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004 J Am Geriatr Soc 55 583-589
[2]  
Paulose-Ram R(1996)Outcome of unreconstructed chronic critical leg ischaemia Eur J Vasc Endovasc Surg 11 153-157
[3]  
Dillon CF(1997)Critical and subcritical ischaemia Eur J Vasc Endovasc Surg 13 578-582
[4]  
Lepantalo M(2000)Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC) J Vasc Surg 31 S1-S296
[5]  
Matzke S(1998)The noninvasive vascular laboratory Surg Clin North Am 78 507-518
[6]  
Wolfe JH(1997)Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry Radiology 203 611-620
[7]  
Wyatt MG(1992)Arteriographic complications in the DSA era Radiology 182 243-246
[8]  
Dormandy JA(2000)Imaging of aortoiliac arterial disease. Duplex ultrasound and MR angiography versus digital subtraction angiography Acta Radiol 41 125-132
[9]  
Rutherford RB(2000)Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography AJR Am J Roentgenol 174 171-179
[10]  
Gahtan V(2007)Lower extremity arterial disease: multidetector CT angiography meta-analysis Radiology 245 433-439